More than 2 years after drugs contaminated with a virulent fungus killed 64 patients and caused related illnesses in another 687, Medicare-approved hospital accreditors still don’t properly oversee contracts hospitals have with compounding pharmacies to assure these drugs are safe, according to an Office of Inspector General report.

It recommends the Centers for Medicare and Medicaid Services (CMS) consider requiring 55 practices for accreditors to use to oversee compounded sterile preparations (CSPs).

“Contracting with standalone pharmacies for CSPs gets limited attention from the oversight entities,” the OIG report says.

Continue Reading

READ FULL ARTICLE Curated publisher From Medical Page Today